BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15720389)

  • 21. Identification of the N- and C-terminal substrate binding segments of ferredoxin-NADP+ reductase by NMR.
    Maeda M; Lee YH; Ikegami T; Tamura K; Hoshino M; Yamazaki T; Nakayama M; Hase T; Goto Y
    Biochemistry; 2005 Aug; 44(31):10644-53. PubMed ID: 16060673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Degradation of morpholine, piperidine, and pyrrolidine by mycobacteria: evidences for the involvement of a cytochrome P450.
    Poupin P; Godon JJ; Zumstein E; Truffaut N
    Can J Microbiol; 1999 Mar; 45(3):209-16. PubMed ID: 10408093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo interactions of ferredoxin-NADP+ reductases in Pseudomonas putida.
    Yeom J; Jeon CO; Madsen EL; Park W
    J Biochem; 2009 Apr; 145(4):481-91. PubMed ID: 19122206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and characterization of a functional canine variant of cytochrome b5 reductase.
    Roma GW; Crowley LJ; Barber MJ
    Arch Biochem Biophys; 2006 Aug; 452(1):69-82. PubMed ID: 16814740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tailoring an alien ferredoxin to support native-like P450 monooxygenase activity.
    Bell SG; McMillan JH; Yorke JA; Kavanagh E; Johnson EO; Wong LL
    Chem Commun (Camb); 2012 Dec; 48(95):11692-4. PubMed ID: 23104016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of the species-specific subdomain and the N-terminal peptide of Toxoplasma gondii ferredoxin-NADP+ reductase in ferredoxin binding.
    Pandini V; Caprini G; Tedeschi G; Seeber F; Zanetti G; Aliverti A
    Biochemistry; 2006 Mar; 45(11):3563-71. PubMed ID: 16533038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative structural-functional characterization of recombinant and natural adrenodoxin. Interaction with cytochrome P450scc.
    Lepesheva GI; Azeva TN; Strushkevich NV; Adamovich TB; Cherkesova TS; Usanov SA
    Biochemistry (Mosc); 1999 Sep; 64(9):1079-88. PubMed ID: 10521726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ferredoxin-NADP+ reductase and ferredoxin of the protozoan parasite Toxoplasma gondii interact productively in Vitro and in Vivo.
    Pandini V; Caprini G; Thomsen N; Aliverti A; Seeber F; Zanetti G
    J Biol Chem; 2002 Dec; 277(50):48463-71. PubMed ID: 12370173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial expression and purification of the Arabidopsis NADPH-cytochrome P450 reductase ATR2.
    Hull AK; Celenza JL
    Protein Expr Purif; 2000 Apr; 18(3):310-5. PubMed ID: 10733884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzymatic reduction of hemoglobins M.
    Nagai M; Yoneyama Y
    Biomed Biochim Acta; 1983; 42(11-12):S159-63. PubMed ID: 6675686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of [3Fe-4S] ferredoxin DbfA3, which functions in the angular dioxygenase system of Terrabacter sp. strain DBF63.
    Takagi T; Habe H; Yoshida T; Yamane H; Omori T; Nojiri H
    Appl Microbiol Biotechnol; 2005 Aug; 68(3):336-45. PubMed ID: 15717172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ferredoxin and ferredoxin reductase activities in bovine thyroid. Possible relationship to iodotyrosine deiodinase.
    Goswami A; Rosenberg IN
    J Biol Chem; 1981 Jan; 256(2):893-9. PubMed ID: 6778876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activities and kinetic mechanisms of native and soluble NADPH-cytochrome P450 reductase.
    Lamb DC; Warrilow AG; Venkateswarlu K; Kelly DE; Kelly SL
    Biochem Biophys Res Commun; 2001 Aug; 286(1):48-54. PubMed ID: 11485306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzymatic oxidation of NADP+ to its 4-oxo derivative is a side-reaction displayed only by the adrenodoxin reductase type of ferredoxin-NADP+ reductases.
    de Rosa M; Pennati A; Pandini V; Monzani E; Zanetti G; Aliverti A
    FEBS J; 2007 Aug; 274(15):3998-4007. PubMed ID: 17635583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ferredoxin-NADP(+) reductase uses the same site for the interaction with ferredoxin and flavodoxin.
    Martínez-Júlvez M; Medina M; Gómez-Moreno C
    J Biol Inorg Chem; 1999 Oct; 4(5):568-78. PubMed ID: 10550685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiological, biochemical, and genetic characterization of an alicyclic amine-degrading Mycobacterium sp. strain THO100 isolated from a morpholine-containing culture of activated sewage sludge.
    Kim YH; Kang I; Bergeron H; Lau PC; Engesser KH; Kim SJ
    Arch Microbiol; 2006 Nov; 186(5):425-34. PubMed ID: 16912859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering of recombinant E. coli cells co-expressing P450pyrTM monooxygenase and glucose dehydrogenase for highly regio- and stereoselective hydroxylation of alicycles with cofactor recycling.
    Pham SQ; Gao P; Li Z
    Biotechnol Bioeng; 2013 Feb; 110(2):363-73. PubMed ID: 22886996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the polyene macrolide P450 epoxidase from Streptomyces natalensis that converts de-epoxypimaricin into pimaricin.
    Mendes MV; Antón N; Martín JF; Aparicio JF
    Biochem J; 2005 Feb; 386(Pt 1):57-62. PubMed ID: 15228385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzymatic properties of terephthalate 1,2-dioxygenase of Comamonas sp. strain E6.
    Fukuhara Y; Kasai D; Katayama Y; Fukuda M; Masai E
    Biosci Biotechnol Biochem; 2008 Sep; 72(9):2335-41. PubMed ID: 18776687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome mining in Amycolatopsis balhimycina for ferredoxins capable of supporting cytochrome P450 enzymes involved in glycopeptide antibiotic biosynthesis.
    Geib N; Weber T; Wörtz T; Zerbe K; Wohlleben W; Robinson JA
    FEMS Microbiol Lett; 2010 May; 306(1):45-53. PubMed ID: 20337711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.